nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0308	0.0308	CcSEcCtD
Anagrelide—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.0293	0.0293	CcSEcCtD
Anagrelide—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.0235	0.0235	CcSEcCtD
Anagrelide—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0233	0.0233	CcSEcCtD
Anagrelide—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.0215	0.0215	CcSEcCtD
Anagrelide—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0213	0.0213	CcSEcCtD
Anagrelide—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0189	0.0189	CcSEcCtD
Anagrelide—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.0183	0.0183	CcSEcCtD
Anagrelide—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.0179	0.0179	CcSEcCtD
Anagrelide—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.0163	0.0163	CcSEcCtD
Anagrelide—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.0161	0.0161	CcSEcCtD
Anagrelide—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.016	0.016	CcSEcCtD
Anagrelide—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.0158	0.0158	CcSEcCtD
Anagrelide—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.0153	0.0153	CcSEcCtD
Anagrelide—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.0145	0.0145	CcSEcCtD
Anagrelide—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0141	0.0141	CcSEcCtD
Anagrelide—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.0131	0.0131	CcSEcCtD
Anagrelide—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0127	CcSEcCtD
Anagrelide—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0124	0.0124	CcSEcCtD
Anagrelide—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.0124	0.0124	CcSEcCtD
Anagrelide—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0121	0.0121	CcSEcCtD
Anagrelide—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0119	CcSEcCtD
Anagrelide—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.0113	CcSEcCtD
Anagrelide—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.0111	0.0111	CcSEcCtD
Anagrelide—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0107	CcSEcCtD
Anagrelide—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.0104	0.0104	CcSEcCtD
Anagrelide—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0102	CcSEcCtD
Anagrelide—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.01	CcSEcCtD
Anagrelide—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.01	CcSEcCtD
Anagrelide—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00975	0.00975	CcSEcCtD
Anagrelide—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00963	0.00963	CcSEcCtD
Anagrelide—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00949	0.00949	CcSEcCtD
Anagrelide—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00943	0.00943	CcSEcCtD
Anagrelide—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00935	0.00935	CcSEcCtD
Anagrelide—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00927	0.00927	CcSEcCtD
Anagrelide—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00916	0.00916	CcSEcCtD
Anagrelide—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00914	0.00914	CcSEcCtD
Anagrelide—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00911	0.00911	CcSEcCtD
Anagrelide—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00904	0.00904	CcSEcCtD
Anagrelide—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00904	0.00904	CcSEcCtD
Anagrelide—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00886	0.00886	CcSEcCtD
Anagrelide—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00879	0.00879	CcSEcCtD
Anagrelide—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00877	0.00877	CcSEcCtD
Anagrelide—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00872	0.00872	CcSEcCtD
Anagrelide—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00839	0.00839	CcSEcCtD
Anagrelide—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00837	0.00837	CcSEcCtD
Anagrelide—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00835	0.00835	CcSEcCtD
Anagrelide—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00835	0.00835	CcSEcCtD
Anagrelide—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0083	0.0083	CcSEcCtD
Anagrelide—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00828	0.00828	CcSEcCtD
Anagrelide—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00824	0.00824	CcSEcCtD
Anagrelide—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0082	0.0082	CcSEcCtD
Anagrelide—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00818	0.00818	CcSEcCtD
Anagrelide—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00804	0.00804	CcSEcCtD
Anagrelide—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00778	0.00778	CcSEcCtD
Anagrelide—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00752	0.00752	CcSEcCtD
Anagrelide—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00749	0.00749	CcSEcCtD
Anagrelide—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00746	0.00746	CcSEcCtD
Anagrelide—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00737	0.00737	CcSEcCtD
Anagrelide—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00726	0.00726	CcSEcCtD
Anagrelide—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00716	0.00716	CcSEcCtD
Anagrelide—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00713	0.00713	CcSEcCtD
Anagrelide—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00706	0.00706	CcSEcCtD
Anagrelide—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00698	0.00698	CcSEcCtD
Anagrelide—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00685	0.00685	CcSEcCtD
Anagrelide—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00674	0.00674	CcSEcCtD
Anagrelide—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00671	0.00671	CcSEcCtD
Anagrelide—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00655	0.00655	CcSEcCtD
Anagrelide—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00634	0.00634	CcSEcCtD
Anagrelide—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00629	0.00629	CcSEcCtD
Anagrelide—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00627	0.00627	CcSEcCtD
Anagrelide—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00618	0.00618	CcSEcCtD
Anagrelide—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00618	0.00618	CcSEcCtD
Anagrelide—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00618	0.00618	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00614	0.00614	CcSEcCtD
Anagrelide—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00611	0.00611	CcSEcCtD
Anagrelide—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00605	0.00605	CcSEcCtD
Anagrelide—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00598	0.00598	CcSEcCtD
Anagrelide—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00593	0.00593	CcSEcCtD
Anagrelide—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00589	0.00589	CcSEcCtD
Anagrelide—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00581	0.00581	CcSEcCtD
Anagrelide—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00581	0.00581	CcSEcCtD
Anagrelide—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00576	0.00576	CcSEcCtD
Anagrelide—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00573	0.00573	CcSEcCtD
Anagrelide—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00565	0.00565	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0054	0.0054	CcSEcCtD
Anagrelide—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00536	0.00536	CcSEcCtD
Anagrelide—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00532	0.00532	CcSEcCtD
Anagrelide—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00529	0.00529	CcSEcCtD
Anagrelide—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00527	0.00527	CcSEcCtD
Anagrelide—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00522	0.00522	CcSEcCtD
Anagrelide—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00515	0.00515	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00512	0.00512	CcSEcCtD
Anagrelide—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00511	0.00511	CcSEcCtD
Anagrelide—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00507	0.00507	CcSEcCtD
Anagrelide—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00507	0.00507	CcSEcCtD
Anagrelide—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.00489	CcSEcCtD
Anagrelide—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00485	0.00485	CcSEcCtD
Anagrelide—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00471	0.00471	CcSEcCtD
Anagrelide—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00469	0.00469	CcSEcCtD
Anagrelide—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00469	0.00469	CcSEcCtD
Anagrelide—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00425	0.00425	CcSEcCtD
Anagrelide—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00419	0.00419	CcSEcCtD
Anagrelide—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00406	0.00406	CcSEcCtD
Anagrelide—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00392	0.00392	CcSEcCtD
Anagrelide—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00377	0.00377	CcSEcCtD
Anagrelide—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00374	0.00374	CcSEcCtD
Anagrelide—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00373	0.00373	CcSEcCtD
Anagrelide—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00371	0.00371	CcSEcCtD
Anagrelide—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00352	0.00352	CcSEcCtD
